Latest Licensing Agreements News

Hazer Group has forged a strategic alliance with engineering giant KBR to fast-track commercial deployment of its methane pyrolysis technology, supported by a $10.7 million capital raise and promising project developments in Japan.

FirstWave Cloud Technology has secured a $770k contract renewal with Microsoft, marking an 18% uplift and signaling strong growth potential through new AI-powered products and expanded licensing.

Activeport Group Ltd has secured a landmark contract to deploy its advanced network orchestration software across Ishan Technologies’ vast Indian infrastructure, automating connectivity for over 12,000 edge devices and enhancing service delivery for 85,000 customers.

MedAdvisor Limited has finalized the sale of its Australian and New Zealand operations to Jonas Software for an estimated $42.35 million, marking a strategic pivot towards its US business. The company also announced upcoming CFO changes as it refocuses its growth trajectory.

Lithium Universe has completed legal due diligence on its acquisition of New Age Minerals, securing exclusive rights to a patented solar panel recycling technology. This move positions the company to expand its sustainable footprint in the lithium supply chain.

MedAdvisor Limited has entered a binding agreement to sell its ANZ business division and intellectual property to Jonas Software for a headline price of $35 million plus an uncapped earn-out. The deal marks a strategic pivot as MedAdvisor focuses on its US operations.

Neurizon Therapeutics has inked a pivotal global licensing deal with Elanco Animal Health, unlocking critical intellectual property and data to accelerate the development and commercialisation of its lead drug candidate NUZ-001 for neurodegenerative diseases including ALS.

FirstWave Cloud Technology has secured a $400,000 AUD licensing agreement with Claro Dominican Republic, marking a strategic expansion into Latin America's telecom sector.

ECS Botanics has launched the globally acclaimed Terphogz™ cannabis strains, including The Original Z™, into the Australian medicinal market, marking a strategic expansion of its premium product portfolio.

Percheron Therapeutics has licensed HMBD-002, a promising immuno-oncology monoclonal antibody targeting VISTA, from Hummingbird Bioscience, marking a strategic pivot after recent setbacks. The company plans to initiate phase II trials in 2026, aiming to advance this novel cancer therapy toward commercialisation.

Microba Life Sciences announces a $12.5 million equity raise, including a strategic $8.3 million investment from Sonic Healthcare, aiming to fuel growth in the UK and achieve regional break-even by FY26.

Jayride Group launches a new B2B SaaS platform aimed at transforming ground transportation with integrated payments, fleet management, and AI tools, promising higher margins and scalable growth.